Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease.

Biotechnology

Pharmaceutical

Eledon Pharmaceuticals

David-Alexandre C. Gros

Eliezer Katz

Paul Little

John Herberger

Carmen Mak

David Hovland

Bryan Smith

Steven Perrin

The executive team at Eledon Pharmaceuticals has extensive experience in the pharmaceutical industry, with many members having worked at Takeda, Biogen Idec, and ALS TDI. They hold degrees from Duke University, Boston University School of Medicine, and Boston College.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Eledon Pharmaceuticals

Leadership Team

Board of Directors